Skip to Main

Search

Results 871 to 880 of 1,046 for ""

UT Southwestern ranked among 20 Best Employers for Diversity, top health care institution : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/top-employers-diversity-forbes.html

UT Southwestern Medical Center is one of the nation’s best employers for diversity, according to America’s Best Employers 2022 list compiled by Forbes and Statista.

Newly identified bacteria-killing protein needs vitamin A to work: Newsroom, UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2019/bacteria-killing-protein.html

UT Southwestern researchers identified a previously unknown bacteria-killing protein on the epidermis that requires the vitamin to work.

Newborn boys are more vulnerable than girls to asphyxia: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/nov-newborn-boys-girls.html

– Newborn boys are significantly more likely than girls to have a brain injury called hypoxic-ischemic encephalopathy (HIE), researchers at UT Southwestern Medical Center and Children’s Health Dallas report.

First structure of human cotransporter protein family member solved: Newsroom - UT Southwestern, Dallas, TX

https://www.utsouthwestern.edu/newsroom/articles/year-2019/cotransporter-protein.html

In work that could someday improve treatments for epilepsy, UT Southwestern scientists have published the first three-dimensional structure of a member of a large family of human proteins that carry charged particles – ions – across the cell membrane.

Discovery fuels insights into early developmental disorders: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/dec-early-developmental-disorders.html

A new study led by UT Southwestern Medical Center molecular biologists presents a novel culture system to grow both embryonic and extraembryonic stem cells, potentially providing important insights into the genesis of congenital malformations and early developmental disorders.

AI can spot early signs of Alzheimer’s in speech patterns, study shows: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/april-alzheimers-in-speech-patterns.html

New technologies that can capture subtle changes in a patient’s voice may help physicians diagnose cognitive impairment and Alzheimer’s disease before symptoms begin to show.

Inappropriate disclosure to vendor announced: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/inappropriate-disclosure.html

UT Southwestern Medical Center has informed affected patients of an inappropriate disclosure of their email addresses through use of a third-party vendor.

Sickle cell patients face higher risks in joint reconstruction surgeries: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/april-joint-reconstruction-surgeries.html

Patients with sickle cell disease (SCD) who undergo total knee replacement are at higher risk for complications than non-SCD patients, according to a large-scale, retrospective study by researchers from UT Southwestern Medical Center and the University of Calgary.

UT Southwestern’s new GammaPod advances breast cancer care: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2019/gamma-pod.html

UT Southwestern now offers more precise radiation treatments for breast cancer with a new, cutting-edge device that is only the second of its kind in the world.

Healthy gut bacteria can help fight cancer in other parts of the body, UTSW researchers find: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/march-healthy-gut-bacteria.html

Researchers at UT Southwestern Medical Center have discovered how healthy bacteria can escape the intestine, travel to lymph nodes and cancerous tumors elsewhere in the body, and boost the effectiveness of certain immunotherapy drugs.